NCT01924520View on ClinicalTrials.gov

Oral Multiple-dose Study in Patients With Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

FK949E

Oral

Trial Locations (2)

Unknown

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01924520 - Oral Multiple-dose Study in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter